Showing results (11-20 of 1,121) with videos related to
Sort By:
Pageof 113
Chinese Journal of Cancer|March 18, 2016
Survival and clinical outcomes in patients with metastatic epidural spinal cord compression after spinal surgery: a prospective, multicenter, observational cohort studyAnick Nater, Michael G FehlingsNeurosurgical Focus|November 5, 2008
Prevention, identification, and treatment of perioperative spinal cord injuryHenry Ahn, Michael G FehlingsExperimental Neurology|September 3, 2013
Do omega-3 polyunsaturated fatty acids ameliorate spinal cord injury?: Commentary on: Lim et al., Improved outcome after spinal cord compression injury in mice treated with docosahexaeonic acid. Exp. Neurol. Jan; 239:13-27Kajana Satkunendrarajah, Michael G FehlingsJournal of Neurosurgery|October 18, 2003
Clinical and radiological evaluation of the Codman semiconstrained load-sharing anterior cervical plate: prospective multicenter trial and independent blinded evaluation of outcomeSteven Casha, Michael G FehlingsJournal of Neurotrauma|March 15, 2002
Development and characterization of a novel, graded model of clip compressive spinal cord injury in the mouse: Part 1. Clip design, behavioral outcomes, and histopathologyMital Joshi, Michael G FehlingsJournal of Neurosurgery. Spine|September 23, 2009
Surgical management of cervical degenerative disease: the evidence related to indications, impact, and outcomeMichael G Fehlings, Babak ArvinWorld Neurosurgery|January 10, 2013
Rho-ROCK inhibition in the treatment of spinal cord injuryNicole Forgione, Michael G FehlingsCurrent Stem Cell Research & Therapy|December 29, 2012
Mesenchymal cells in the treatment of spinal cord injury: current & future perspectivesReaz Vawda, Michael G FehlingsStem Cells Translational Medicine|March 9, 2023
Incorporating Combinatorial Approaches to Encourage Targeted Neural Stem/Progenitor Cell Integration Following Transplantation in Spinal Cord InjuryKatarzyna Pieczonka, Michael G FehlingsExpert Opinion on Investigational Drugs|February 4, 2015
Investigational drugs for the treatment of spinal cord injury: review of preclinical studies and evaluation of clinical trials from Phase I to IINarihito Nagoshi, Michael G FehlingsPageof 113